Patent Yard Sign in
Canadian application, no grantCanada

Device which can be applied in bone and/or tissue in the human body, and method and use of said device

CA 2470729 A1 · Owner: Nobel Biocare Ab (Publ) · Inventors: Andersson, Matts; Eriksson, Mikael

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A device, for example in the form of an implant is arranged to be applied via , at least one surface or one portion (for example an outer portion) to bone and/or tissue in the human body. An agent which stimulates bone growth in the , form of HA, is used in connection with the device. The device the surface or , the portion comprises or consists of compressed bone-compatible and/or tissuecompatible material in the form of titanium powder. The titanium powder is mixed with the agent, which is also in powder form and a composite material , is formed with the two powders by means of impact compaction. The invention also relates to a method and use in connection with devices of the type in …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 19, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 19, 2002
GrantedNo grant recorded
Term endedDecember 19, 2022
Patent numberCA 2470729 A1
Classification (IPC)A61C8/00 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedDec 19, 2002Term endedDec 19, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.